HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

United Arab Emirates Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


United Arab Emirates Radiopharmaceutical Synthesizer Market Insights

  • Based on Reed Intelligence findings, the United Arab Emirates Radiopharmaceutical Synthesizer Market reached USD 131.92 Million in 2024 and is estimated to attain USD 190.91 Million by 2033.
  • From 2026 to 2033, the United Arab Emirates market is expected to grow at a steady CAGR of 4.18%.
  • Within the Modality category, PET dominated in 2024 in terms of market size contribution.
  • Over the forecast period, SPECT is forecasted to deliver the fastest growth, positioning it as the most lucrative Modality segment.

Other Key Findings


  • United Arab Emirates contributed 4.21% to the global Radiopharmaceutical Synthesizer Market size in 2024.
  • By 2033, United States is forecasted to remain the largest global market for Radiopharmaceutical Synthesizer Market.
  • In Middle East and Africa, United Arab Emirates is projected to capture the leading share of market size by 2033.
  • Among Middle East and Africa markets, Turkey is expected to post the fastest growth, reaching USD 23.16 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 131.92 Million
Market Size In 2033 USD 190.91 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.18% (2025-2033)
Segmnetation Covered
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports